NCT06524544
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06524544
Title A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Care Specialists of Illinois - Decatur RECRUITING Decatur Illinois 62526 United States Details
Decatur Memorial Hospital RECRUITING Decatur Illinois 62526 United States Details
Crossroads Cancer Center RECRUITING Effingham Illinois 62401 United States Details
Southern Illinois University School of Medicine RECRUITING Springfield Illinois 62702 United States Details
Parkland Health Center - Farmington RECRUITING Farmington Missouri 63640 United States Details
Sainte Genevieve County Memorial Hospital RECRUITING Sainte Genevieve Missouri 63670 United States Details
Missouri Baptist Medical Center RECRUITING St Louis Missouri 63131 United States Details
Missouri Baptist Sullivan Hospital RECRUITING Sullivan Missouri 63080 United States Details
BJC Outpatient Center at Sunset Hills RECRUITING Sunset Hills Missouri 63127 United States Details
West Virginia University Charleston Division RECRUITING Charleston West Virginia 25304 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field